GLP-1/glucagon dual agonists*

Skarbaliene, J., Madsen, A.N., Mouritzen, U., Bak, H.H., and Just, R.
Exploring the therapeutic potential of glucagon/GLP-1 receptor dual agonist ZP2929 in a mouse model of diet induced and biopsy-confirmed non-alcoholic steatohepatitis
Poster, the International Liver Congress (EASL), Amsterdam, 2017

Fosgerau, K., Skovgaard, M., Larsen, S., Meier, E., Bæk, C., Grøndahl, C.
The new glucagon-GLP-1 dual agonist ZP2929 in combination with long-acting insulin improves glycemic control without causing weight gain in db/db mice.
Poster, American Diabetes Association (ADA) 71st Scientific Sessions, San Diego, USA, June 24–28, 2011.

Fosgerau, K., Skovgaard, M., Larsen, S.A., Baek, C&Aelig, Meier, E., Groendahl, C., and Bak, H.H.
Combination of Long-Acting Insulin with the Dual GluGLP-1 Agonist ZP2929 Causes Improved Glycemic Control without Body Weight Gain in db/db Mice
Diabetes, 2011 Jul 1, Vol.60 Suppl 1, pp.A418-A418.

* Partnered with Boehringer Ingelheim